Pulmonary artery stents-still "off label"
- PMID: 22363377
- PMCID: PMC3283761
- DOI: 10.4070/kcj.2012.42.1.8
Pulmonary artery stents-still "off label"
Conflict of interest statement
The author has no financial conflicts of interest.
Comment on
- Korean Circ J. 42:40.
References
-
- Fogelman R, Nykanen D, Smallhorn JF, McCrindle BW, Freedom RM, Benson LN. Endovascular stents in the pulmonary circulation: clinical impact on management and medium-term follow-up. Circulation. 1995;92:881–885. - PubMed
-
- McMahon CJ, El-Said HG, Grifka RG, Fraley JK, Nihill MR, Mullins CE. Redilation of endovascular stents in congenital heart disease: factors implicated in the development of restenosis and neointimal proliferation. J Am Coll Cardiol. 2001;38:521–526. - PubMed
-
- O'Laughlin MP, Slack MC, Grifka RG, Perry SB, Lock JE, Mullins CE. Implantation and intermediate-term follow-up of stents in congenital heart disease. Circulation. 1993;88:605–614. - PubMed
-
- Shaffer KM, Mullins CE, Grifka RG, et al. Intravascular stents in congenital heart disease: short- and long-term results from a large single-center experience. J Am Coll Cardiol. 1998;31:661–667. - PubMed
LinkOut - more resources
Full Text Sources
